Director/PDMR Shareholding

RNS Number : 9957D
GlaxoSmithKline PLC
12 July 2016
 

GlaxoSmithKline plc (the 'Company')

Transaction notification

 

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Sir Andrew Witty

b)

Position/status

CEO

c)

Initial notification/

amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial  instrument

Ordinary shares of 25 pence each

ISIN: GB0009252882

 

 

 

 

 

 

 

b)

Nature of the transaction

Acquisition of ordinary shares under the Company's ShareReward Plan

 

c)

Price(s) and

volume(s)

Price(s)

Volume(s)

£16.7127

7 (partnership shares)

£16.7127

7 (matching shares)

  

 

d)

Aggregated information

 

Aggregated volume Price

 

 

 

 

14 Ordinary shares

£16.7127 

 

e)

Date of the transaction

2016-07-11 (12:18 GMT)

f)

Place of the transaction

 

London Stock Exchange (XLON)

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHQLLFFQDFLBBV

Companies

GSK (GSK)
UK 100

Latest directors dealings